chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a Doctor of pharmacy concerning a female baby (1-2) days old who on approximately on 05-July-2009 was vaccinated with RUBELLA (lot # not reported) instead YEAST (manufacturer unknown). Reported as human error. On an unspecified date she received YEAST (manufacturer unknown) (lot # not reported). No adverse effects were reported. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available.
Case previously recorded as MA2009-5499. Initial case report received from consumer on 21 NOV 2009. 2 year old patient was vaccinated i.m. for the first time with S-OIV FLUVIRIN on 19 Nov 2009.
Patient stated that she had been feeling bad since the morning. She was told she needed to be vaccinated and went to the SRP site for her vaccinations around 1100. Patient stated that she told vaccinators her symptoms. The vaccinator informed patient that because she did not have a fever, she would receive the vaccines. Patient reports having chills and feeling cold during the day before vaccination. Since vaccination, she has vomited x3, fatigued, cough/sneeze, abd pain, sore throat.
Information has been received from a pharmacist concerning a 37 year old male with a history of a splenectomy who on 28-MAR-2007 was vaccinated with an entire 5 dose vial of Pneumovax 23.  The vaccine was administered by a nurse who injected all 5 doses thinking it was a unit dose vial.  On 28-MAR-2007 the patient developed a large local reaction (rash) in the deltoid region which has since subsided.  Additional information has been requested.
Initial report received from a healthcare professional, who is also patient's brother, on 30 July 2012. A 58-year-old female patient, whose medical history and concomitant medication was reported as none; had received intramuscular dose of ADACEL vaccine in right deltoid (lot number C3974AA) on 23 July 2012. The patient's ongoing illness included none. On 29 July 2012 i.e. after 6 days, the patient presented swelling under right arm and an area of bruising under the arm, sore from elbow to wrist, and area under arm is painful to touch injection site of arm is not red or swollen. The patient's relevant diagnostic tests and lab data were reported as none. The patient's outcome was not recovered. Documents held by sender: None. The follow-up information received on 15 October 2012 from a healthcare professional, who is also patient's sister. It was reported that within a week of reporting adverse event the patient fully recovered. The swelling and redness were gone and no treatment was necessary.
Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Medium, Systemic: Nausea-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Shakiness-Medium
rash and Pruritis  at injection sight started small on 5/16/2020 and grew larger redder and increased pruritis over the next 24 hours. Patient has only taken one dose of benydrl 25mg to help with sleep.   recommendations given:  Apply a cold compress to the site for approximately 15 minutes if the patient has any inflammation/swelling/or soreness. Recommend an analgesic such as acetaminophen or non-steroid anti-inflammatory drug. An anti-histamine can be used for any swelling make sure to observe and discuss with the patient signs of generalized anaphylaxis Apply firm pressure to the site and raise the arm above heart level for excessive bleeding
Chills, 100.5 fever, headache and vaccination sight pain and redness.
Tiredness, general feeling of unwellness, over 4 months time weight loss, type-2 diabetes diagnosis, death.  Patient had blood clots and physicians could not determine the source of the bleeding.
parent described excessive somulence (uncharacteristic) for 48 hrs p/vax given; no fever, no crying, no sz activity; seemed lethargic w/pallor; slept approx 20 hrs of 1st 24 hrs w/fitful dozing; no shock-like sx, no hypotonia;
Patient was double vaccinated with Moderna, but tested positive 11-29-2021. Pt had a 'mild' illness with COVID. Pt was able to resume work after quarantine period.
After receiving the vaccine rec'd yesterday afternoon around 2pm and today about 9 I felt extremely exhausted and have to take nap.
Fever (102.3) Chills Sweats Dizziness Aches Fatigue Lethargic Soreness at injection site (radiating through arm) red and raised bump at injection site warm to touch on injection site
one shot and neglected to get another; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, 3 years after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced shingles and incomplete course of vaccination. On an unknown date, the outcome of the shingles was recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported for the first dose and not applicable for the second dose. The patient got one shingle shot and 3 years later got shingles that lasted almost a year. The patient stated that he/ she neglected to get another, years later got shingles and had just got over them, lasted months.
Raised, red, hard rash at injection site 10/24/13. Raised, red, hard rash 1.5 inch x 1.5 inch/insomnia/Irritable 10/26/13 (ER visit at suggestion of on call pediatrician). x3 pox at injection site, x 2 pox on back, fever 10/27/13. Pediatrician visit 10/28/13.
shortness of breath, heart palpitations, panic attacks, night sweats,chills, small bumps on right hand second day after vaccine, fatigue
Slight redness noticed next am on 03/26/2002 with some swelling by late afternoon. More redness and swelling and itching this am on 03/27/2002. Office visit made to recheck.
I am just frustrated with my pain; Fatigue; Nausea; Diarrhea; I am very sick and I had very bad last night because of nausea and diarrhea, it doesn't seem to stop or go away; It just did not stop; This is a spontaneous report from a contactable consumer. This 65-year-old female consumer (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN6206) via an unspecified route of administration on 12Mar2021 (at 65-year-old) on left arm as dose 1, single and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EP7533) via an unspecified route of administration on 01Apr2021 (at This 65-year-old) as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 14Mar2021 patient was very sick and I had very bad last night because of nausea and diarrhea, it did not seem to stop or go away. She was sick every day and it just did not stop. It was because of both the shots or I should say, it never went away after the first shot and She said, she had an adverse event after she got both the Covid shots. She said she had fatigue. On an unknown date she was frustrated with her pain. Also, she said that she does have chronic health problem. Also, she contacted her doctor and they gave her couple of medications but her symptoms were still pretty bad. For treatment of events consumer stated, her medication was changed and it had not improved her situation, they changed the dose in it. One of the medication was Zonisamide, they increased the dosage hoping that it would improve the nausea but it did not. So, the medication that treat chronic health condition they were trying to treat to help me but it was not helping at all, it did not make any sense. The event outcome was unknown.  There was a Product Complaint.  Follow-up attempts were not needed. Further information was not expected.
After second dose--slightly sore arm for one day; chills; slight body aches; slight headache; This is a spontaneous report from a non-contactable non-healthcare professional.   A 48-years-old female patient received first dose of BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration, administered in arm left on 19Jan2021 at 11:45 as first single dose for covid-19 immunisation. after first dose patient had slightly sore arm for 3 days and second dose of BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration, administered in arm left on 09Feb2021 at 12:30 as second single dose for covid-19 immunisation.  Medical history included food allergy (allergies: freshwater prawns) and concomitant medications were not reported. the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnose with COVID-19. Since the vaccination, not had the patient been tested for COVID-19. On 10Feb2021 at 08:00, the patient experienced after second dose slightly sore arm for one day, chills, slight body aches and slight headache. Patient was not treatment received for the adverse event. The outcome of the events was recovered o an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
8 days p/inject had mild temp followed by papular red rash from face shoulder spreading to extremities over 4 days; rash on leg was more macular, purple (yet blanchy) & lacy appearance
pt recv ax 20JUL96 & 20 & 21JUL rt shoulder was sore;22JUL pt noted weakness of rt triceps & shoulder & should joint pain;also noted dec sensation i rt long & index finger tips; this persisted & presented for eval 1AUG;
It's been 4 days since my vaccine and I still have pain, swelling, redness and itching in the area .. the swelling is really big .. what can I do to ease this discomfort .. can't sleep at night.
10/2 through 10/3 fever 99- 100F.  Mild headache and moderate stiff painful posterior neck through 10/7.  10/5 through day of this report itchy skin/mild rash extremities requiring Benadryl once daily for symptoms. Tachycardia with occasional palpalpations began 10/4. Heart rate at rest 106. Heart rate with mild activity up to 125-130 with diaphoresis. Tachycardia continued next day so sought care at urgent care for concern of heart or vaccine issue.  No ST changes with 12 lead. Dr advised this to be overreaction of immune system and inflammatory response. Advised 600 Ibuprofen once to twice a day.  Ongoing fatigue is still improving. Still taking  Ibuprofen/ Benadryl  to minimize symptoms. 10/10 tachycardia with HR up to 120?s with moderate activity improved by end day. This week heart rate improved. Fatigue improved.  Skin reaction ongoing. Did not report skin issues to MD.
SIGNIFICANT ARM SWELING AND PAIN DECREASED OVER NEXT 24  HOURS.
This spontaneous report as received from a Pediatrician participating in market research refers to a pre-adolescent female patient. On an unknown date the patient was vaccinated with her first dose of GARDASIL. Pediatrician reporting during interview that he observed "faintness and dizziness" in the patient after receiving first in a series of 3 injections of GARDASIL. Patient was taken to a nearby ER, where she recovered after a few hours and sent home. Date and other details of the patient were not recalled. Patient received the rest of the series without incident. The reporter considered faintness and dizziness to be related to GARDASIL. Additional information has been requested.
Pain in hands after vaccination; Swollen hands after vaccination; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PAIN IN EXTREMITY (Pain in hands after vaccination) and PERIPHERAL SWELLING (Swollen hands after vaccination) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Cancer (Patient went through chemo and radiation. The cancer went away.) in 2020, Chemotherapy and Radiation therapy.   In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced PAIN IN EXTREMITY (Pain in hands after vaccination) and PERIPHERAL SWELLING (Swollen hands after vaccination). At the time of the report, PAIN IN EXTREMITY (Pain in hands after vaccination) and PERIPHERAL SWELLING (Swollen hands after vaccination) outcome was unknown.            No concomitant medication information was provided.  Patient took 2 Moderna vaccine shots and then booster.  Ever since vaccination, patient started having pain in hands and swollen hands.  Treatment included pain medication.   This case was linked to MOD-2022-659356 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Oct-2022: Live Follow-up appended contains non significant information. On 14-Oct-2022: Live Follow-up appended contains non significant information.
Extensive pruritus and mild urtiaria with premedication with Benadry, zyrtec and pepcid.
First Pfizer vaccination shot given at 11am, felt fine until 9pm that night then sudden onset dizzy, lips tingling, then cheeks swelled and got very red, low grade fever 99.7F. Took 50mg benadryl within 10 mins of initial symptoms and another 25mg an hour later after talking to the oncall doctor.
Skin rash on third day after administration of first dose. One day after the second dose of vaccination, I was tired, dizzy, headache, nausea, cold sweat, and after I loss consciousness for approximately 30 seconds, paramedics came to my house and measured my levels of glucose, blood pressure, and electrocardiogram they were in normal range.
This case was reported by a pharmacist and described the occurrence of injection site pain in a subject of unspecified age and gender who was vaccinated with FLUARIX Quadrivalent (.5 ml, unknown batch number, left arm). Within days of vaccination with FLUARIX Quadrivalent, the subject experienced pain and soreness at injection site. At the time of reporting, the outcome of the events were unspecified. Additional information received on 06 October 2014: The patient received 1st dose of FLUARIX Quadrivalent (batch number 2KJ3T, expiry date was unknown). On 4th September 2014, less than a day after receiving FLUARIX Quadrivalent, the patient experienced injection site pain and soreness. On 9th September 2014, the outcome of the events were resolved. The reporter considered the injection site pain and pain to be probably related to FLUARIX Quadrivalent.
Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: allergic reaction initially she's doing fine now
Red area about 3 inches long and 2 inches wide about 1/8 inch below injection site. Very itchy, hot, and painful.
I looked at the box that had the flu shot too fast and mistaked the number of the month. After the vaccine was administered mom had left already so  the doctor gave the mom a call.
This spontaneous report was received from a medical assistant that was also an office manager concerning a 4 year old patient of unknown gender. There was no information about the patient's concurrent conditions, medical history or concomitant medication. On 25-AUG-2017 the patient was vaccinated with the first dose of PROQUAD for prophylaxis (dose and route of administration were not reported) lot number N004361 and expiration date of 07-AUG-2018. Then, on 22-SEP-2017, the patient received a second dose of PROQUAD for prophylaxis (dose, route of administration, lot number and expiration date were not reported). Subsequently, on 20-NOV-2017, the patient was administered a dose of VARIVAX lot # M042858 and expiration date of 21-OCT-2018, subcutaneous for prophylaxis. It was also reported an improperly stored vaccine administered (no details provided). No adverse effects were reported.
24h after injection had induration at site; 48h after injection developed edema and severe pain extended from LUE to axilla, supraclavicular region and left neck
sore arm; Initial information received on 18-Oct-2021 regarding an unsolicited valid non-serious case received from a consumer or non-healthcare professional via social media.  This case involved adult patient who experienced sore arm (pain in extremity) after receiving vaccine INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor.   The patient past medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious sore arm (pain in extremity) (unknown latency) following the administration of INFLUENZA VACCINE.  It was unknown if there were lab data/results available.  It was reported "Got my flu shot last week. I had no side effects at all. I didn't even have a sore arm this time."  It was unknown if the patient experienced any additional symptoms/events.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was unknown for the reported event.  There will be no information available on the batch number for this case.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX vaccine to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 01-JUL-2011, a healthcare provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 05-DEC-2016, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Limited mobility of arm. Arm swollen, red, hot to touch. Applied ice, took pain medication.
pt recvd vax & 3 days following vax red papular urticaria severe itch began on chest area-quickly spreading to all southern region-then spreading to all Northern areas; oozing vesicles covering entire body including face & scalp; swelling;
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) . The reporter is the patient.  A 36-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Nov2021 as dose 3 (booster), single (Lot number: 33030BD) at the age of 36 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing), notes: Known allergies: Penicillin; "Hypothyroid" (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: The patient received anti-viral product for COVID 19 Treatment with Brand Paxlovid, treatment start date 13May2022, treatment stop date 17May2022. The patient experienced Itchy back and body 1 day after completing Paxlovid, taste is gone and vision is little blurry.
experienced a mild allergic reaction, her throat was kinda closing but she can still breathe.; experienced a mild allergic reaction, her throat was kinda closing but she can still breathe.; This is a spontaneous report from Pfizer sponsored program . A contactable consumer (on behalf of patient) reported a female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 16Mar2021, at a single dose for COVID-19 immunisation. The patient medical history and concomitant medication were not reported. On an unknown date in 2021, patient experienced a mild allergic reaction, her throat was kinda closing but she can still breathe (as reported) and wanted to know if someone who had a mild allergic reaction after receiving the 1st dose can that someone still get the second dose. The reporter escalated because patient experienced a mild allergic reaction after receiving the first dose. The outcome of the event was unknown.  Information about batch/lot number has been requested.
He has been diagnosed with stage 4 cancer; lumps all over the left side of his body; some on his neck, back, arms, a very large one on his left leg that is wrapped around the muscle in his leg.; Her dad took the booster shot; This is a spontaneous report from a contactable consumer. A male patient of unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot: Unknown) via unspecified route on unspecified date as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received Dose 1 and Dose 2 of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) on unspecified dates as single doses for COVID-19 immunization. It was reported that the patient took the booster shot and he has now developed lumps all over the left side of his body; some on his neck, back, arms, a very large one on his left leg that is wrapped around the muscle in his leg. He has been diagnosed with stage 4 cancer. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
besides the symptoms that I mentioned before, now I have a intense pain in the axilla of the injected arm.  is very painful and it doesn't improve
Loss of taste and smell starting after second vaccine and continuing until now. She was unable to smell burning food.
Child was given Varicella SQ & immediately developed 6mm raised area on right leg at injection site.
p/vax pt devel hives;the hives have not resolved;pt MD recommended DPH & calamine, pramoxine HCl, alcohol,camphor, diazolindinyl urea, caladryl;